Selected readings
- Bedrossian CW, Warren CJ, Ohar J, et al. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocyto- chemistry. Ann Diagn Pathol 1997; 1(1): 47–56
- Jessurun GA, Boers ma WG, Crijns HJ. Amiodarone-induced pulmonary toxicity: predisposing factors, clinical symptoms and treatment. Drug Saf 1998; 18(5): 339–44
- Kennedy JI Jr. Clinical aspects of amiodarone pulmonary toxtcity. Clin Chest Med 1990; 11(1): 119–29
- Mermolja M, Rott T, Debeljak A. Cytology of bronchoalveolar lavage in some rare pulmonary disorders: pulmonary alveolar proteinosis and amiodarone pulmonary toxicity. Cytopathology 1994; 5(1): 9–16
- Pollack PT. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol 1999; 84(9A): 37–45R